Accenture plc

(New York Stock Exchange)
Back to all articles
Bullish +75

Accenture Stock Gets 2 Price Target Cuts Today β€” Is the AI Revenue Story Falling Apart?

AI-generated analysis

πŸ“ˆ Accenture beat Q2 FY26 earnings estimates with EPS of $2.93 on $18.04B in revenue, an 8.3% year-over-year increase.

πŸ“‘ New bookings reached a record high of $22.11 billion, including deals from over 41 large clients exceeding $100 million each.

πŸš€ Management raised full-year guidance for free cash flow to between $10.8B and $11.5B, up from the previous $9.8B-$10.5B range.

πŸ“‰ Despite strong financial results, Accenture shares dropped significantly following the earnings report due to diverging analyst sentiments.

πŸ”¨ Two Wall Street firms cut their price targets on the stock today, citing concerns about the sustainability of revenue growth.

⚠️ Analysts worry that AI adoption may structurally reduce demand for traditional IT consulting and managed services contracts rather than creating new growth.

πŸ’¬ CEO Julie Sweet defended the business model on a conference call, claiming strong AI-driven growth across enterprise clients.

πŸ” The company highlighted $2.2 billion in advanced AI new bookings in Q1 FY26 and $5.9 billion in gen AI bookings for the full year 2025.

βš–οΈ A key debate remains whether AI revenue is additive or if it acts as a replacement that compresses long-term margins.

πŸ₯ The Health & Public Service segment declined 1% in local currency, adding uncertainty to the company's growth trajectory.

πŸ“Š Accenture reported an elevated effective tax rate of 24.3% compared to 20.4% a year ago, which could pressure net income growth.

🎯 Q3 FY26 revenue is expected to be between $18.35 billion and $19.0 billion as investors await further validation of the AI narrative.

Bullish Signals
  • Accenture beat earnings estimates again in Q2 FY26 with EPS of $2.93 versus a $2.84 estimate.
  • The company posted record bookings of $22.11 billion, with over 41 clients booking more than $100 million in the quarter.
  • Management raised full-year guidance for free cash flow to $10.8B-$11.5B, up from the previous guidance of $9.8B-$10.5B.
  • Total revenue reached $18.04 billion, representing an 8.3% year-over-year increase against estimates.
  • CEO Julie Sweet confirmed strong AI-driven growth, citing $2.2 billion in advanced AI new bookings in Q1 FY26.
  • Accenture highlighted $5.9 billion in gen AI bookings for all of FY25 as evidence of a robust pipeline.
Risk Factors
  • Despite beating earnings estimates and raising full-year guidance, Accenture's stock fell sharply to $186.31, indicating a significant disconnect between operational performance and market sentiment.
  • The stock is now down 23.69% year to date and 35.81% over the past year while the analyst consensus target sits at $268.51, highlighting substantial downside risk relative to current prices.
  • Two Wall Street firms cut their price targets today due to bearish concerns that AI could structurally reduce the need for large-scale IT consulting and managed services contracts rather than driving new revenue growth.
  • There is a specific fear that if AI enables clients to operate with fewer consultants and hours, Accenture may face margin compression over time by replacing traditional revenue streams instead of adding to them.
  • The Health & Public Service segment declined 1% in local currency, raising concerns about weakness in one of the company's key business areas despite overall top-line strength.
  • An elevated effective tax rate of 24.3% compared to 20.4% a year ago creates pressure on net income growth that could offset strong revenue performance.
  • The upcoming Q3 FY26 revenue guidance range of $18.35B-$19.0B will serve as the next critical test for whether the AI story is compounding or stalling.
Full Analysis
Accenture (NYSE: ACN) reported strong quarterly results on Thursday, surpassing earnings estimates with Q2 FY26 EPS of $2.93 and revenue of $18.04 billion, an 8.3% year-over-year increase. The company posted record bookings totaling $22.11 billion, with 41 clients contributing more than $100 million in the quarter, and management raised full-year free cash flow guidance to between $10.8 billion and $11.5 billion from a previous range of $9.8 billion to $10.5 billion. Despite this positive financial performance, the stock price fell sharply to $186.31 in the hour following the filing, reflecting significant market disconnection as the share has declined 23.69% year-to-date and 35.81% over the past year. Two Wall Street firms recently cut their price targets for Accenture amidst growing analyst skepticism regarding whether artificial intelligence is truly generating new revenue or merely shrinking the overall IT spending pie that fuels the company's growth. BMO and another unnamed firm expressed concern that AI functions primarily as an efficiency tool allowing clients to do more with fewer consultants, potentially leading to structural margin compression over time rather than acting as a net-new revenue driver. This bearish perspective questions if Accenture can add incremental revenue from AI without displacing traditional consulting work, noting that the stock trades well below the analyst consensus target of $268.51 despite recent price cuts. During the earnings call, CEO Julie Sweet defended the company's position, citing $2.2 billion in advanced AI new bookings for Q1 FY26 and $5.9 billion in generative AI bookings for all of FY25 as evidence that the AI pipeline remains robust. However, the tension between reported AI growth and stock performance may only resolve when Accenture can demonstrate that AI bookings are additive to traditional revenue streams rather than a replacement. Key indicators analysts are monitoring include the stabilization of the Health & Public Service segment, which declined 1% in local currency, and the pressure from an elevated effective tax rate of 24.3% compared to 20.4% last year. The upcoming Q3 FY26 revenue guidance, projected between $18.35 billion and $19.0 billion, is expected to serve as the next critical test for whether the AI growth story is compounding or stalling.